Asuragen Receives Notice of Allowance from USPTO
Asuragen Inc has received a Notice of Allowance from the United States Patent and Trademark Office.
Read MoreSearch Results for: lung cancer
Insight Genetics Awarded Phase I SBIR Contract
Posted by Clinical Lab Products | Nov 11, 2010 | Cancer, Miscellaneous |
Insight Genetics has been awarded a $200,000 Phase I Small Business Innovation Research contract from the National Cancer Institute.
Read MorePresenters Discuss Oncimmune Blood Test at CHEST
Posted by Clinical Lab Products | Nov 4, 2010 | Cancer, Miscellaneous |
Two oral presentations and five poster presentations during CHEST 2010 will collectively highlight the clinical and economic benefits of Oncimmune’s EarlyCDT-Lung.
Read MoreRPC, Provista Sign 5-Year Laboratory Services Agreement
Posted by Clinical Lab Products | Nov 3, 2010 | Cancer, Miscellaneous |
Radient Pharmaceuticals Corporation has entered into an exclusive 5-year laboratory services agreement with Provista Diagnostics Inc.
Read MoreGE Healthcare to Acquire Clarient Inc
Posted by Clinical Lab Products | Oct 25, 2010 | Cancer, Miscellaneous |
GE Healthcare, a unit of General Electric Company, and Clarient Inc announced have entered into a definitive agreement for GE Healthcare to acquire Clarient.
Read More